Check our latest news and where we are going to be soon.

2702, 2023

AST’s Cutting Edge of Transplantation 2023

Biohope reperesented by our CEO, Isabel Portero, participated in the CEOT 2023. American Society of Transplantation (AST) organized a new edition of "Cutting Edge of Transplantation" (CEoT) 2023 - Embracing New Frontiers in Transplantation. The event focused

1211, 2022

52º Congreso de la Sociedad Española de Nefrología

Oral communication C Jimenez, D Valencia , Mo Lopez, Me Gonzalez, Ma Moreno, A De Santos, A Ortega, T Diez, I Portero, A Sánchez-fructuoso. “Caracterización de los parámetros del Immunobiogram, un nuevo método para la medida in

310, 2022

The TRANSBIO study demonstrates the usefulness of Immunobiogram® for predicting the response to different immunosuppressive treatments in transplant recipients

The results have been published in the high-impact journal Transplant immunology. TRANSBIO, a multicenter, international clinical study, has demonstrated the correlation of the in-vitro measurement of the patient's pharmacodynamic response to immunosuppressive drugs, using the Immunobiogram® diagnostic

804, 2022

BIOHOPE will be part of the European Pavilion at BIO 2022

BIOHOPE has been selected by the European Innovation Council (EIC) as one of the 20 European biotech companies to participate at BIO International Convention 2022, the world's largest biotechnology exhibition. Under the framework of the EIC Overseas